For example, patients with certain GLP1R variants may experience stronger appetite suppression at lower doses, suggesting a slower escalation is optimal
Ozempic, initially prescribed for managing type 2 diabetes, has proven to be highly effective for weight management, particularly for individuals who have struggled with traditional weight-loss methods
PMID: 37622681
By activating both GIP and GLP-1 receptors, tirzepatide: Enhances insulin secretion in response to elevated blood glucose levels Suppresses glucagon release , reducing hepatic glucose production Slows gastric emptying , promoting satiety and reducing appetite Acts on brain appetite centres , helping to reduce caloric intake Common adverse effects include nausea, diarrhoea, decreased appetite, vomiting, constipation, and abdominal discomfort
The hidden GLP-1 connection Here is something fascinating that most articles about this combination miss entirely
Prioritizing overall health requires vigilance regarding these potential side effects while pursuing weight loss goals